4A Cameron,M Ewen,D Ross-Degnan,D Ball,R Laing.Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis[J]. The Lancet . 2009 (9659)
5World Health Organization.The selection of essential drugs:report of a WHO expert committee. Journal of Women s Health . 1977
6World Health Organization.WHO Drug In-formation. Journal of Women s Health . 2007
7Newton Paul N,Lee Sue J,Goodman Catherine,Fernández Facundo M,Yeung Shunmay,Phanouvong Souly,Kaur Harparkash,Amin Abdinasir A,Whitty Christopher J M,Kokwaro Gilbert O,Lindeg?rdh Niklas,Lukulay Patrick,White Lisa J,Day Nicholas P J,Green Mic.Guidelines for field surveys of the quality of medicines: a proposal. PLoS medicine . 2009
8Chen Wen,Tang Shenglan,Sun Jing,Ross-Degnan Dennis,Wagner Anita K.Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces. BMC health services research . 2010
9Michael A Albert,Atle Fretheim,Diadié Ma?ga.Factors influencing the utilization of research findings by health policy-makers in a developing country: the selection of Mali’s essential medicines. Health Research Policy and Systems . 2007
10World Health Organization.Promoting rational use of medicines:core components. Journal of Women s Health . 2002
